Literature DB >> 12103263

Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation.

Cevher Ozcan1, Arshad Jahangir, Paul A Friedman, David L Hayes, Thomas M Munger, Robert F Rea, Margaret A Lloyd, Douglas L Packer, David O Hodge, Bernard J Gersh, Stephen C Hammill, Win-Kuang Shen.   

Abstract

OBJECTIVES: We evaluated the incidence and predictors of sudden death after atrioventricular (AV) node ablation and pacemaker implantation.
BACKGROUND: Sudden death may occur after radiofrequency catheter ablation of the AV node and pacemaker implantation in patients with atrial fibrillation (AF). Whether it is related to the procedure or to pre-existing heart disease remains unclear.
METHODS: All patients who had radiofrequency catheter ablation of the AV node and pacemaker implantation for rate control of medically refractory AF were identified retrospectively and observed prospectively. All patients with sudden death after ablation were identified. The relationship between the procedure and sudden death was defined on the basis of the time between the two as "likely," "possibly" or "unlikely."
RESULTS: Of 334 consecutive patients with AF who underwent AV node ablation, nine had sudden death after the ablation. Four patients (1.2%) had sudden death likely related to the procedure: in 3 patients, arrest occurred within 48 h after the procedure; in one patient, arrest occurred four days after the procedure. In three other patients (0.9%), sudden death was possibly related to the procedure because the event occurred within three months afterward. The remaining two deaths were unrelated to the procedure. Diabetes, New York Heart Association functional class (>or=II), preprocedure ventricular arrhythmia, mitral or aortic stenosis, aortic regurgitation and chronic obstructive pulmonary disease were independent predictors for sudden death.
CONCLUSIONS: Sudden death likely or possibly related to catheter ablation occurred in 7 of 334 patients (2.1%). Risk of sudden death is highest within two days after the procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12103263     DOI: 10.1016/s0735-1097(02)01927-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

Review 2.  Rate Control in Atrial Fibrillation: Avoiding Morbidity.

Authors:  Thomas D Callahan
Journal:  J Atr Fibrillation       Date:  2012-12-16

3.  Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation.

Authors:  Ru-Xing Wang; Hon-Chi Lee; Jia-Ping Li; David O Hodge; Yong-Mei Cha; Paul A Friedman; Thomas M Munger; Komandoor Srivathsan; Behzad B Pavri; Win-Kuang Shen
Journal:  Clin Cardiol       Date:  2016-10-17       Impact factor: 2.882

4.  Device-based therapies for atrial fibrillation.

Authors:  Gregory K Bruce; Paul A Friedman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

5.  Rituximab-induced polymorphic ventricular tachycardia.

Authors:  Joseph T Poterucha; Mark Westberg; Pamela Nerheim; James P Lovell
Journal:  Tex Heart Inst J       Date:  2010

6.  Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome.

Authors:  Yasutsugu Nagamoto; Tomohito Inage; Teruhisa Yoshida; Tomohiro Takeuchi; Takeki Gondo; Yujiro Fukuda; Eiichi Takii; Kenta Murotani; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-04-20       Impact factor: 2.037

7.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 8.  Alternatives to warfarin for thromboembolism prophylaxis in nonrheumatic atrial fibrillation.

Authors:  Ramin Artang; Humberto Vidaillet
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 9.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 10.  Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device.

Authors:  Finn Akerström; Moisés Rodríguez Mañero; Marta Pachón; Alberto Puchol; Xesús Alberte Fernández López; Luis Martínez Sande; Miguel Valderrábano; Miguel A Arias
Journal:  J Atr Fibrillation       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.